The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: A multistate model

Breast Cancer Research and Treatment

Volumn 117, Issue 2, 2009, Pages 401-408

  De Bock, G H ^a   Putter, H ^b   Bonnema, J ^c   Van Der Hage, J A ^b   Bartelink, H ^d   Van De Velde, C J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS OF MORECAMBE BAY NHS FOUNDATION TRUST   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Distant metastasis; Follow up studies; Local recurrences; Meta analysis; Multistate model; Prognostic factors; Survival analysis; Women

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ADVANCED CANCER; AGE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; DISTANT METASTASIS; EARLY CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL; TUMOR VOLUME;

ADULT; AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS;

EID: 68949129241     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0300-2     Document Type: Article

References (39)

1. B Fisher S Anderson ER Fisher 1991 Significance of ipsilateral breast tumour recurrence after lumpectomy Lancet 338 327 331 10.1016/0140-6736(91) 90475-5
2. JA Van Dongen AC Voogd IS Fentiman 2000 Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial J Natl Cancer Inst 92 1143 1150 10.1093/jnci/92.14.1143
3. B Fisher S Anderson J Bryant 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233 1241 10.1056/NEJMoa022152
4. U Veronesi N Cascinelli L Mariani 2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 1227 1232 10.1056/NEJMoa020989
5. R Arriagada MG Le JM Guinebretiere A Dunant F Rochard T Tursz 2003 Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients Ann Oncol 14 1617 1622 10.1093/annonc/mdg452
6. Early Breast Cancer Trialists' Collaborative Group 1995 Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group N Engl J Med 333 1444 1455 10.1056/NEJM199511303332202
7. AC Voogd M Nielsen JL Peterse 2001 Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 1688 1697
8. N Kroman H Holtveg J Wohlfahrt 2004 Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma Cancer 100 688 693 10.1002/cncr.20022
9. Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH (2008) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat [Epub ahead of print]
10. M Clarke R Collins S Darby 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106
11. J Van Dongen H Bartelink IS Fentiman 1992 Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial J Natl Cancer Inst Monogr 11 15 18
12. JA Van Dongen H Bartelink IS Fentiman 1992 Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer Eur J Cancer 28A 801 805 10.1016/0959-8049(92)90118-L
13. PC Clahsen C Van de Velde JP Julien 1996 Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer, Breast Cancer Cooperative Group Study J Clin Oncol 14 745 753
14. PH Elkhuizen HJ Van Slooten PC Clahsen 2000 High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study J Clin Oncol 18 1075 1083
15. J Van der Hage C Van deVelde JP Julien 2001 Improved survival after one course of perioperative chemotherapy in early breast cancer patients. Long-term results from the European Organization for Research and Treatment of Cancer (EORTC) trial 10854 Eur J Cancer 37 2184 2193 10.1016/S0959-8049(01)00294-5
16. J Van der Hage CJ Van de Velde JP Julien M Tubiana-Hulin C Vandervelden L Duchateau 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 4224 4237
17. P Broet A De la Rochefordiere SM Scholl 1999 Analyzing prognostic factors in breast cancer using a multistate model Breast Cancer Res Treat 54 83 89 10.1023/A:1006197524405
18. H Putter M Fiocco RB Geskus 2007 Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2389 2430 10.1002/sim.2712
19. I Soerjomataram MW Louwman JG Ribot JA Roukema JW Coebergh 2007 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 309 330 10.1007/s10549-007-9556-1
20. R Arriagada LE Rutqvist H Johansson A Kramar S Rotstein 2008 Predicting distant dissemination in patients with early breast cancer Acta Oncol 47 1113 1121 10.1080/02841860701829661
21. G Coulombe S Tyldesley C Speers 2007 Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 67 1282 1290 10.1016/j.ijrobp.2006.11.032
22. MA Bollet B Sigal-Zafrani V Mazeau 2007 Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first Radiother Oncol 82 272 280 10.1016/j.radonc.2007.01.001
23. JG Van Nes CJ Van de Velde 2006 The preferred treatment for young women with breast cancer-mastectomy versus breast conservation Breast 15 Suppl 2 S3 S10 10.1016/S0960-9776(07)70009-7
24. H Kemperman J Borger A Hart H Peterse H Bartelink J Van Dongen 1995 Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence Eur J Cancer 31A 690 698 10.1016/0959-8049(94)00526-B
25. E Touboul L Buffat Y Belkacemi 1999 Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer Int J Radiat Oncol Biol Phys 43 25 38 10.1016/S0360-3016(98)00365- 4
26. D Cowen J Jacquemier G Houvenaeghel P Viens B Puig VJ Bardou M Resbeut D Maraninchi 1998 Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up Int J Radiat Oncol Biol Phys 41 801 807 10.1016/S0360-3016(98)00144-8
27. J Engel R Eckel U Aydemir S Aydemir J Kerr A Schlesinger-Raab P Dirschedl D Hölzel 2003 Determinants and prognoses of locoregional and distant progression in breast cancer Int J Radiat Oncol Biol Phys 55 1186 1195 10.1016/S0360-3016(02)04476-0
28. PH Elkhuizen J Hermans JW Leer MJ Van de Vijver 2001 Late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis Int J Radiat Oncol Biol Phys 50 387 396 10.1016/S0360-3016(01)01469-9
29. A Fourquet F Campana B Zafrani 1989 Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up Int J Radiat Oncol Biol Phys 17 719 725
30. M Van der Sangen L Van de Poll-Franse RM Roumen 2006 The prognosis of patients with local recurrence more than 5 years after breast conservation therapy for invasive breast carcinoma Eur J Surg Oncol 32 34 38 10.1016/j.ejso.2005.10.005
31. RS Punglia M Morrow EP Winer JR Harris 2007 Local therapy and survival in breast cancer N Engl J Med 356 2399 2405 10.1056/NEJMra065241
32. WS Halsted 1907 The results of radical operations for the cure of carcinoma of the breast Ann Surg 46 1 19
33. B Fisher 1980 Laboratory and clinical research in breast cancer-a personal adventure: the David A. Karnofsky Memorial Lecture Cancer Res 40 3863 3874
34. J Ragaz SM Jackson N Le 1997 Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 956 962 10.1056/NEJM199710023371402
35. HM Nielsen M Overgaard C Grau AR Jensen J Overgaard 2006 Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials Radiother Oncol 79 147 155 10.1016/j.radonc.2006.04.006
36. H Bartelink JC Horiot PM Poortmans 2007 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 3259 3265 10.1200/JCO.2007.11.4991
37. L Livi M Stefanacci S Scoccianti 2007 Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery Clin Oncol (R Coll Radiol) 19 120 124 10.1016/j.clon.2006.11.006
38. M Van der Leest L Evers MJ Van der Sangen 2007 The safety of breast-conserving therapy in patients with breast cancer aged ≤40 years Cancer 109 1957 1964 10.1002/cncr.22639
39. C Vrieling L Collette A Fourquet 2003 Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39 932 944 10.1016/S0959-8049(03)00123-0